Personalis

Personalis Assets per Share

The Total Assets per Share of Personalis (PSNL) as of Nov 2, 2026 is 3.76 USD. In the previous year, Total Assets per Share was 3.04 USD — a change of 23.64% (higher).

Assets per Share

3.76USD

YoY

23.64%

Last updated:

Total Assets per Share of Personalis is 2025 3.76 USD. Total Assets per Share of Personalis was 2024 3.04 USD. It decreases by 23.64% higher compared to the previous year.

The Personalis Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.47 USD
Jan 1, 2019
1.77 USD
Jan 1, 2020
2.76 USD
Jan 1, 2021
4.47 USD
Jan 1, 2022
3.30 USD
Jan 1, 2023
2.53 USD
Jan 1, 2024
3.04 USD
Jan 1, 2025
3.76 USD
The Personalis Assets per Share history
YEARAssets per ShareYoY
3.76USD+23.64%
3.04USD+20.07%
2.53USD-23.10%
3.30USD-26.18%
4.47USD+61.95%
2.76USD+55.66%
1.77USD+277.47%
0.47USD+24.15%
0.38USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Personalis Stock analysis

What does Personalis do? Personalis Inc is a diagnostic company specializing in the development of tests for personalized medicine. The company was founded in 2011 by Dr. Richard Chen and Dr. Erin Newburn and is headquartered in Menlo Park, California. They initially focused on developing genomic tools for cancer diagnosis and treatment but have expanded their offerings to include tests for rare genetic diseases, immunotherapies, and precision oncology drugs. They work closely with pharmaceutical and biotechnology companies as well as academics to develop innovative therapeutic approaches. Their business model is based on making genomics biology usable for personalized medicine and clinical research. They have a wide portfolio of genomic-based solutions for personalized medicine, including tests for tumor mutations, tumor-specific neoantigens, rare genetic diseases, and personalized immunotherapy. They also offer customized genomic solutions for pharmaceutical and biotechnology companies. Personalis Inc aims to establish personalized medicine quickly and effectively to provide the best possible outcome for patients. Personalis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Personalis stock

Total Assets per Share of Personalis is 3.76 USD in 2025.

Total Assets per Share of Personalis changed from 3.04 USD to 3.76 USD, representing a 23.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Personalis since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Personalis

All Key Metrics — Personalis